Viatris, formed through the combination of Mylan and Upjohn, is a global healthcare company bridging the gap between generics and brands to address healthcare needs globally. Driven by a mission to help people live healthier at every stage of life, we supply high-quality medicines to 1 billion patients annually. Our diverse portfolio, unique supply chain, and scientific expertise enable us to meet the world’s most enduring health challenges, ensuring access to vital treatments when and where needed.